New herbal manufacturing facility for Sami-Sabinsa Group

State-of-the-art pharmaceutical manufacturing facility creates 250 jobs, strengthens India’s nutraceutical and cosmeceutical production capacity.

Sami-Sabinsa Group has inaugurated its ninth pharmaceutical manufacturing facility, the Hassan Unit-2 herbal production plant in Karnataka’s Pharma SEZ Industrial Area. The $15 million investment significantly expands India’s cosmeceutical manufacturing and standardised herbal extracts production capacity.

The cGMP-certified manufacturing facility was officially opened on 5 December 2025. Dr Anju Majeed, executive group chairperson, led the ceremony alongside Karnataka Legislative Assembly Member Dr HD Ranganath.

“This new herbal ingredients manufacturing facility will strengthen our ability to serve global customers with both patented herbal products and off-patent nutraceuticals,” said Dr Anju Majeed. “It is expected to significantly enhance Sami-Sabinsa Group’s export performance and contribute to substantial revenue growth in the pharmaceutical manufacturing sector.”

Zero liquid discharge technology

The 15-acre herbal production facility joins Hassan Unit-1, Sami-Sabinsa’s NSF GMP-certified API manufacturing plant established in 2020 in the same Pharma SEZ Industrial Area. Hassan Unit-2 represents the company’s commitment to sustainable pharmaceutical manufacturing through advanced Zero Liquid Discharge (ZLD) technology.

The environmentally conscious manufacturing facility is fully compliant with current Good Manufacturing Practices (cGMP) standards. It will generate employment for 250 people in the Hassan pharmaceutical manufacturing sector. Strategic expansion planning reserves 30% to 40% of land for future herbal ingredients production growth.

Hassan’s strategic location in Karnataka provides convenient access to India’s east and west coast ports. This enhances the company’s pharmaceutical export capabilities and supports the Make in India initiative for nutraceutical manufacturing.

Sustainable manufacturing and environmental leadership

The eco-friendly manufacturing facility demonstrates industry leadership in sustainable pharmaceutical production through:

• Zero Liquid Discharge (ZLD) technology with no external effluent release.
• Green belt covering 30% of the total facility area.
• Two independent Effluent Treatment Plants (ETPs) for wastewater management.
• Multiple Effect Evaporator (MEE) system for sustainable water processing.
• Rainwater harvesting systems and dedicated collection channels.
• 100% power backup through comprehensive generator systems.
• Steam boilers, vacuum systems, and cooling compressors for optimal production.

Industry impact and market expansion

The Hassan Unit-2 launch reinforces India’s position as a global pharmaceutical manufacturing hub and supports the country’s herbal medicine export growth. It strengthens Sami-Sabinsa‘s ingredient portfolio expansion while focusing on innovative herbal product development for the international nutraceutical and cosmeceutical markets.